Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
A Review of Cardiovascular Involvements Associated With Medications Used to Treat Covid-19 Infection Publisher



Afshar ZM1 ; Babazadeh A2 ; Janbakhsh A1 ; Bayani M2 ; Ramezani E3 ; Khaneshan AS4 ; Ebrahimpour S2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
  2. 2. Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
  3. 3. Department of Cardiology, Kermanshah University of Medical Sciences, Kermanshah, Iran
  4. 4. Department of Infectious Diseases, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran

Source: Cor et Vasa Published:2021


Abstract

Coronavirus disease 2019 (COVID-19) pandemic has spread rapidly across the world and is introduced as a global health crisis. COVID-19 is one of the threatening pandemics in history involving many organs, including the cardiovascular system. The cardiovascular involvements, such as myocardial injury, myocarditis, acute myocardial infarction, dysrhythmias, and heart failure, have been reported in the COVID-19 patients. Currently, there is no specific antiviral treatment for COVID-19; though, some therapies such as interferon, remdesivir, ribavirin, favipiravir, and tocilizumab are being used. The medications used to treat COVID-19 may have cardiovascular adverse events or interact with some cardiovascular drugs. The most concerning conditions caused by these medications are QTc prolongation and torsades de pointes (TdP), which might cause abrupt death. Here, we describe cardiac adverse effects and potential interactions of COVID-19 medications with cardiovascular agents. © 2021, CKS.
Related Docs
View other Related Docs
1. The Situation of Small Molecules Targeting Key Proteins in Combatting Sars-Cov-2: Synthesis, Metabolic Pathway, Mechanism of Action, and Potential Therapeutic Applications, Mini-Reviews in Medicinal Chemistry (2022)
2. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)
3. What Is Important in Patients With Covid-19 Associated With Myocardial Infarction?, Journal of Tehran University Heart Center (2020)
4. What Is Important in Patients With Covid-19 Associated With Myocardial Infarction?, Journal of Tehran University Heart Center (2020)
5. Cardiovascular Complications of Covid-19: Pharmacotherapy Perspective, Cardiovascular Drugs and Therapy (2021)
6. Breakthrough Sars-Cov-2 Infections After Vaccination: A Critical Review, Human Vaccines and Immunotherapeutics (2022)
7. Pathogenesis, Clinical Manifestations and Complications of Coronavirus Disease 2019 (Covid-19), Future Microbiology (2020)
8. Introduction on Coronavirus Disease (Covid-19) Pandemic: The Global Challenge, Advances in Experimental Medicine and Biology (2021)
Experts (# of related papers)
View all Related Experts
Hossein Khalili (4)
Nima Rezaei (3)
Other Related Docs
9. Novel Therapeutic Approaches for Treatment of Covid-19, Journal of Molecular Medicine (2020)
10. A Randomized Clinical Trial of the Efficacy and Safety of Interferon Β-1A in Treatment of Severe Covid-19, Antimicrobial Agents and Chemotherapy (2020)
11. Recent Findings on the Coronavirus Disease 2019 (Covid-19); Immunopathogenesis and Immunotherapeutics, International Immunopharmacology (2020)
12. Efficacy of Persian Medicine Herbal Formulations (Capsules And Decoction) Compared to Standard Care in Patients With Covid-19, a Multicenter Open-Labeled, Randomized, Controlled Clinical Trial, Phytotherapy Research (2021)
13. Evaluation of the Efficacy of Sofosbuvir Plus Daclatasvir in Combination With Ribavirin for Hospitalized Covid-19 Patients With Moderate Disease Compared With Standard Care: A Single-Centre, Randomized Controlled Trial, Journal of Antimicrobial Chemotherapy (2020)
14. Covid-19: Review of a 21St Century Pandemic From Etiology to Neuro-Psychiatric Implications, Journal of Alzheimer's Disease (2020)
15. A Review on Currently Available Potential Therapeutic Options for Covid-19, International Journal of General Medicine (2020)
16. Molecular Dynamics Analysis Predicts Ritonavir and Naloxegol Strongly Block the Sars-Cov-2 Spike Protein-Hace2 Binding, Journal of Biomolecular Structure and Dynamics (2022)
17. Isolated Severe Thrombocytopenia in a Patient With Covid-19: A Case Report, IDCases (2020)
18. Comprehensive Review of Cardiovascular Complications of Coronavirus Disease 2019 and Beneficial Treatments, Cardiology in Review (2022)
19. Safety and Efficacy of Remdesivir for the Treatment of Covid-19: A Rapid Review of Available Evidence, Health Technology Assessment in Action (2020)
20. Risk Factors of Death in Mechanically Ventilated Covid-19 Patients: A Multi-Center Study From Iran, Acta Medica Iranica (2023)
21. Pathophysiology and Management of Tongue Involvement in Covid-19 Patients, Indian Journal of Otolaryngology and Head and Neck Surgery (2022)
22. Comparing Outcomes of Hospitalized Patients With Moderate and Severe Covid-19 Following Treatment With Hydroxychloroquine Plus Atazanavir/Ritonavir, DARU# Journal of Pharmaceutical Sciences (2020)
23. Efficacy and Safety of Sofosbuvir/ Ledipasvir in Treatment of Patients With Covid-19; a Randomized Clinical Trial, Acta Biomedica (2020)
24. World One-Hundred Days After Covid-19 Outbreak: Incidence, Case Fatality Rate, and Trend, Journal of Education and Health Promotion (2020)
25. Pharmacological Treatments of Covid-19, Pharmacological Reports (2020)
26. Clinical Implications and Indicators of Mortality Among Patients Hospitalized With Concurrent Covid-19 and Myocardial Infarction, Turk Kardiyoloji Dernegi Arsivi (2021)
27. Covid-19 and Cardiovascular Diseases, Advances in Experimental Medicine and Biology (2021)
28. Immunophenotyping Characteristics of Covid-19 Patients: Peripheral Blood Cd8+ Hla-Dr+ T Cells As a Biomarker for Mortality Outcome, Journal of Medical Virology (2023)
29. Covid-19 Associated Central Nervous System Manifestations, Mental and Neurological Symptoms: A Systematic Review and Meta-Analysis, Reviews in the Neurosciences (2021)
30. An Overview on the Treatments and Prevention Against Covid-19, Virology Journal (2023)
31. Dermatological Manifestations Associated With Covid-19: A Comprehensive Review of the Current Knowledge, Journal of Medical Virology (2021)
32. Pharmacotherapy for Prevention and Management of Thrombosis in Covid-19, Seminars in Thrombosis and Hemostasis (2020)
33. Recent Advances in Antibody-Based Immunotherapy Strategies for Covid-19, Journal of Cellular Biochemistry (2021)
34. Cardiovascular Diseases Burden in Covid-19: Systematic Review and Meta-Analysis, American Journal of Emergency Medicine (2021)
35. Proinflammatory and Immunomodulatory Cytokine Mrna Changes by Real-Time Rt-Pcr in Patients With Covid-19 Hospitalization in the Icu and People Recovering From the Disease, Minerva Pneumologica (2020)
36. Covid-19-Associated Pulmonary Embolism: Review of the Pathophysiology, Epidemiology, Prevention, Diagnosis, and Treatment, Seminars in Thrombosis and Hemostasis (2023)
37. The Association Between Cardiac Injury and Outcomes in Hospitalized Patients With Covid-19, Internal and Emergency Medicine (2020)
38. Covid-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods, Anti-Cancer Agents in Medicinal Chemistry (2021)
39. Severe Acute Respiratory Syndrome-Coronavirus-2 Spike (S) Protein Based Vaccine Candidates: State of the Art and Future Prospects, Reviews in Medical Virology (2021)
40. Molecular Mechanisms and Therapeutic Effects of Different Vitamins and Minerals in Covid-19 Patients, Journal of Trace Elements in Medicine and Biology (2022)
41. The Role of Cytokines and Their Antagonists in the Treatment of Covid-19 Patients, Reviews in Medical Virology (2023)
42. Molecular Signaling Pathways, Pathophysiological Features in Various Organs, and Treatment Strategies in Sars-Cov2 Infection, Acta Histochemica (2022)
43. Sars-Cov-2-Related and Covid-19 Vaccine-Induced Thromboembolic Events: A Comparative Review, Reviews in Medical Virology (2022)
44. Convalescent Plasma Against Covid-19: A Broad-Spectrum Therapeutic Approach for Emerging Infectious Diseases, Microorganisms (2020)
45. Classification of the Present Pharmaceutical Agents Based on the Possible Effective Mechanism on the Covid-19 Infection, DARU# Journal of Pharmaceutical Sciences (2020)
46. The Immune System and Covid-19: Friend or Foe?, Life Sciences (2020)
47. Prosthetic Heart Valves and the Covid-19 Pandemic Era: What Should We Be Concerned About?, Journal of Cardiac Surgery (2020)